Congenital Hyperinsulinism - 18 Studies Found

Completed : Long Term Glucose Metabolism in Conservatively Treated Patients With Congenital Hyperinsulinism
: Conservatively Treated CHI Patients
: 2013-03-24
Active, not recruiting : Phase II Safety and Efficacy Study of F-DOPA PET/CT in Children With Hyperinsulinemic Hypoglycemia
:
  • Congenital Hyperinsulinism (CHI)
  • Persiste
    : 2011-10-18
    : Drug: 18 F-DOPA one time injection of 0.08 - 0.16 mCurie/kg of 18F-DOPA
Active, not recruiting : Utility of [F-18] fluoroDOPA for Neonatal Hyperinsulinism
:
  • Congenital Hyperinsulinism
  • Hyperinsulinism
  • Drug: F-DOPA 0.08-0.16 mCi/kg

Available : Study of the Use of [18F]-DOPA in Hyperinsulinemic Hypoglycemia
:
  • Hyperinsulinemic Hypoglycemia, Persistent
  • Congenital Hyperinsulinism : 2015-08-24
    : Drug: 18 F-DOPA Subjects will undergo PET imaging with [18F]-DOPA. All PET imaging will be performed aft
Completed : Sirolimus for the Treatment of Hyperinsulinism
: Hyperinsulinism
: 2015-08-12
: Drug: Sirolimus Subjects will receive 1 mg/m2/day orally for 6 weeks. Maintenance dose will be titrated
Not yet recruiting : Pasireotide in Hyperinsulinemic Hypoglycemia
:
  • Congenital Hyperinsulinism
  • Insulinoma
  • Drug: Pasireotide 0.6Mg Solution for Injection

Completed : 18F-DOPA PET Imaging: an Evaluation of Biodistribution and Safety
:
  • Congenital Hyperinsulinism
  • Neuroblastoma
  • Insulinoma
  • Nesidioblastosis

: 2015-09-24
: Drug: 68Ga-NOTA-exendin-4 68Ga-NOTA-exendin-4 were injected into the patients before the PET/CT scans
<<< Previous